No black box warning on record for Ryzneuta
As of the latest FDA labeling reviewed, Ryzneuta (EFBEMALENOGRASTIM ALFA-VUXW) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ryzneuta medicine page for the complete safety profile.